STOCK TITAN

[144] SPS Commerce, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

ANI Pharmaceuticals (ANIP) – Form 4 filing, 21 Jul 2025. Sr. VP, General Counsel & Secretary Meredith W. Cook reported a tax-related share withholding transaction on 18 Jul 2025.

  • Transaction type: Code F (shares withheld to satisfy taxes on vested restricted stock).
  • Securities affected: 2,071 common shares at an implied price of $66.30, total ≈ $0.14 million.
  • Post-transaction holding: Cook now directly owns 76,874 common shares.
  • Derivative positions: No derivative transactions reported; prior option/RSU holdings unchanged.

The filing reflects routine tax withholding rather than an open-market sale. Cook retains >97% of her pre-vesting equity stake, signalling continued alignment with shareholders. No impact on the company’s operations, earnings outlook or governance structure was disclosed.

ANI Pharmaceuticals (ANIP) – Deposito Form 4, 21 lug 2025. Meredith W. Cook, Senior VP, Consigliere Generale e Segretaria, ha riportato una transazione di trattenuta azionaria per motivi fiscali il 18 lug 2025.

  • Tipo di transazione: Codice F (azioni trattenute per soddisfare le imposte su azioni ristrette maturate).
  • Titoli interessati: 2.071 azioni ordinarie a un prezzo implicito di 66,30 $, per un totale di circa 0,14 milioni di $.
  • Detenzione post-transazione: Cook detiene ora direttamente 76.874 azioni ordinarie.
  • Posizioni derivative: Nessuna transazione derivata segnalata; le posizioni precedenti in opzioni/RSU rimangono invariate.

Il deposito riflette una trattenuta fiscale di routine e non una vendita sul mercato aperto. Cook mantiene oltre il 97% della sua partecipazione azionaria precedente alla maturazione, indicando un continuo allineamento con gli azionisti. Non sono stati segnalati impatti sulle operazioni, sulle previsioni degli utili o sulla struttura di governance della società.

ANI Pharmaceuticals (ANIP) – Presentación Formulario 4, 21 de julio de 2025. Meredith W. Cook, Vicepresidenta Senior, Asesora General y Secretaria, reportó una transacción de retención de acciones relacionada con impuestos el 18 de julio de 2025.

  • Tipo de transacción: Código F (acciones retenidas para cubrir impuestos sobre acciones restringidas adquiridas).
  • Valores afectados: 2,071 acciones ordinarias a un precio implícito de $66.30, total aproximado de $0.14 millones.
  • Posición tras la transacción: Cook posee ahora directamente 76,874 acciones ordinarias.
  • Posiciones derivadas: No se reportaron transacciones derivadas; las posiciones previas en opciones/RSU permanecen sin cambios.

La presentación refleja una retención fiscal rutinaria y no una venta en el mercado abierto. Cook conserva más del 97% de su participación accionaria previa a la adquisición, lo que indica una continua alineación con los accionistas. No se divulgó impacto en las operaciones, perspectivas de ganancias o estructura de gobierno de la empresa.

ANI Pharmaceuticals (ANIP) – Form 4 제출, 2025년 7월 21일. 수석 부사장 겸 법률 고문 및 비서인 Meredith W. Cook가 2025년 7월 18일 세금 관련 주식 원천징수 거래를 보고했습니다.

  • 거래 유형: 코드 F (확정된 제한 주식에 대한 세금 납부를 위한 주식 원천징수).
  • 영향 받은 증권: 암시 가격 $66.30에 2,071 보통주, 총 약 $0.14백만.
  • 거래 후 보유 주식: Cook은 현재 직접 76,874 보통주를 보유하고 있습니다.
  • 파생상품 포지션: 파생상품 거래 보고 없음; 이전 옵션/RSU 보유는 변동 없음.

이번 제출은 공개 시장 매도가 아닌 일상적인 세금 원천징수를 반영합니다. Cook은 행사 전 지분의 97% 이상을 유지하여 주주와의 지속적인 이해 일치를 나타냅니다. 회사 운영, 수익 전망 또는 거버넌스 구조에 대한 영향은 공개되지 않았습니다.

ANI Pharmaceuticals (ANIP) – Dépôt du Formulaire 4, 21 juillet 2025. Meredith W. Cook, Vice-Présidente Senior, Conseillère Générale et Secrétaire, a déclaré une opération de retenue d’actions liée à la fiscalité le 18 juillet 2025.

  • Type d’opération : Code F (actions retenues pour couvrir les impôts sur des actions restreintes acquises).
  • Titres concernés : 2 071 actions ordinaires à un prix implicite de 66,30 $, pour un total d’environ 0,14 million de $.
  • Position après l’opération : Cook détient désormais directement 76 874 actions ordinaires.
  • Positions dérivées : Aucune transaction dérivée signalée ; les positions antérieures en options/RSU restent inchangées.

Le dépôt reflète une retenue fiscale de routine plutôt qu’une vente sur le marché ouvert. Cook conserve plus de 97 % de sa participation avant acquisition, témoignant d’un alignement continu avec les actionnaires. Aucun impact sur les opérations, les perspectives de bénéfices ou la gouvernance de l’entreprise n’a été divulgué.

ANI Pharmaceuticals (ANIP) – Form 4 Einreichung, 21. Juli 2025. Meredith W. Cook, Senior VP, General Counsel & Sekretärin, meldete am 18. Juli 2025 eine steuerbedingte Aktienrückbehaltstransaktion.

  • Transaktionstyp: Code F (Aktien zurückbehalten zur Begleichung von Steuern auf unverfallbare Restricted Stocks).
  • Betroffene Wertpapiere: 2.071 Stammaktien zu einem impliziten Preis von 66,30 $, insgesamt ca. 0,14 Mio. $.
  • Bestand nach der Transaktion: Cook besitzt nun direkt 76.874 Stammaktien.
  • Derivative Positionen: Keine derivativen Transaktionen gemeldet; frühere Optionen/RSU-Bestände unverändert.

Die Einreichung spiegelt eine routinemäßige Steuerabführung wider und keine Verkäufe am offenen Markt. Cook behält über 97 % ihres Aktienanteils vor der Vesting-Periode, was eine weiterhin starke Ausrichtung auf die Aktionäre signalisiert. Keine Auswirkungen auf die Geschäftstätigkeit, Gewinnprognosen oder Governance-Struktur wurden bekanntgegeben.

Positive
  • Executive retains 76,874 shares, indicating continued equity exposure and alignment with shareholders.
Negative
  • 2,071 shares were disposed of (withheld for taxes), mildly increasing share float, though impact is immaterial.

Insights

TL;DR: Routine tax withholding; negligible market impact.

The Code F disposition simply covers payroll taxes on 4,820 vested RSUs. At ≈ $137k, it is immaterial relative to ANIP’s average daily dollar volume and the executive’s remaining 76.9k-share stake. Because there was no discretionary sale, the signal value is neutral. Investors should not read this as a change in insider sentiment. Impact on float and EPS is de minimis.

ANI Pharmaceuticals (ANIP) – Deposito Form 4, 21 lug 2025. Meredith W. Cook, Senior VP, Consigliere Generale e Segretaria, ha riportato una transazione di trattenuta azionaria per motivi fiscali il 18 lug 2025.

  • Tipo di transazione: Codice F (azioni trattenute per soddisfare le imposte su azioni ristrette maturate).
  • Titoli interessati: 2.071 azioni ordinarie a un prezzo implicito di 66,30 $, per un totale di circa 0,14 milioni di $.
  • Detenzione post-transazione: Cook detiene ora direttamente 76.874 azioni ordinarie.
  • Posizioni derivative: Nessuna transazione derivata segnalata; le posizioni precedenti in opzioni/RSU rimangono invariate.

Il deposito riflette una trattenuta fiscale di routine e non una vendita sul mercato aperto. Cook mantiene oltre il 97% della sua partecipazione azionaria precedente alla maturazione, indicando un continuo allineamento con gli azionisti. Non sono stati segnalati impatti sulle operazioni, sulle previsioni degli utili o sulla struttura di governance della società.

ANI Pharmaceuticals (ANIP) – Presentación Formulario 4, 21 de julio de 2025. Meredith W. Cook, Vicepresidenta Senior, Asesora General y Secretaria, reportó una transacción de retención de acciones relacionada con impuestos el 18 de julio de 2025.

  • Tipo de transacción: Código F (acciones retenidas para cubrir impuestos sobre acciones restringidas adquiridas).
  • Valores afectados: 2,071 acciones ordinarias a un precio implícito de $66.30, total aproximado de $0.14 millones.
  • Posición tras la transacción: Cook posee ahora directamente 76,874 acciones ordinarias.
  • Posiciones derivadas: No se reportaron transacciones derivadas; las posiciones previas en opciones/RSU permanecen sin cambios.

La presentación refleja una retención fiscal rutinaria y no una venta en el mercado abierto. Cook conserva más del 97% de su participación accionaria previa a la adquisición, lo que indica una continua alineación con los accionistas. No se divulgó impacto en las operaciones, perspectivas de ganancias o estructura de gobierno de la empresa.

ANI Pharmaceuticals (ANIP) – Form 4 제출, 2025년 7월 21일. 수석 부사장 겸 법률 고문 및 비서인 Meredith W. Cook가 2025년 7월 18일 세금 관련 주식 원천징수 거래를 보고했습니다.

  • 거래 유형: 코드 F (확정된 제한 주식에 대한 세금 납부를 위한 주식 원천징수).
  • 영향 받은 증권: 암시 가격 $66.30에 2,071 보통주, 총 약 $0.14백만.
  • 거래 후 보유 주식: Cook은 현재 직접 76,874 보통주를 보유하고 있습니다.
  • 파생상품 포지션: 파생상품 거래 보고 없음; 이전 옵션/RSU 보유는 변동 없음.

이번 제출은 공개 시장 매도가 아닌 일상적인 세금 원천징수를 반영합니다. Cook은 행사 전 지분의 97% 이상을 유지하여 주주와의 지속적인 이해 일치를 나타냅니다. 회사 운영, 수익 전망 또는 거버넌스 구조에 대한 영향은 공개되지 않았습니다.

ANI Pharmaceuticals (ANIP) – Dépôt du Formulaire 4, 21 juillet 2025. Meredith W. Cook, Vice-Présidente Senior, Conseillère Générale et Secrétaire, a déclaré une opération de retenue d’actions liée à la fiscalité le 18 juillet 2025.

  • Type d’opération : Code F (actions retenues pour couvrir les impôts sur des actions restreintes acquises).
  • Titres concernés : 2 071 actions ordinaires à un prix implicite de 66,30 $, pour un total d’environ 0,14 million de $.
  • Position après l’opération : Cook détient désormais directement 76 874 actions ordinaires.
  • Positions dérivées : Aucune transaction dérivée signalée ; les positions antérieures en options/RSU restent inchangées.

Le dépôt reflète une retenue fiscale de routine plutôt qu’une vente sur le marché ouvert. Cook conserve plus de 97 % de sa participation avant acquisition, témoignant d’un alignement continu avec les actionnaires. Aucun impact sur les opérations, les perspectives de bénéfices ou la gouvernance de l’entreprise n’a été divulgué.

ANI Pharmaceuticals (ANIP) – Form 4 Einreichung, 21. Juli 2025. Meredith W. Cook, Senior VP, General Counsel & Sekretärin, meldete am 18. Juli 2025 eine steuerbedingte Aktienrückbehaltstransaktion.

  • Transaktionstyp: Code F (Aktien zurückbehalten zur Begleichung von Steuern auf unverfallbare Restricted Stocks).
  • Betroffene Wertpapiere: 2.071 Stammaktien zu einem impliziten Preis von 66,30 $, insgesamt ca. 0,14 Mio. $.
  • Bestand nach der Transaktion: Cook besitzt nun direkt 76.874 Stammaktien.
  • Derivative Positionen: Keine derivativen Transaktionen gemeldet; frühere Optionen/RSU-Bestände unverändert.

Die Einreichung spiegelt eine routinemäßige Steuerabführung wider und keine Verkäufe am offenen Markt. Cook behält über 97 % ihres Aktienanteils vor der Vesting-Periode, was eine weiterhin starke Ausrichtung auf die Aktionäre signalisiert. Keine Auswirkungen auf die Geschäftstätigkeit, Gewinnprognosen oder Governance-Struktur wurden bekanntgegeben.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did ANIP insider Meredith Cook report in the Form 4 filed 21-Jul-2025?

She disclosed 2,071 shares of ANIP common stock were withheld on 18-Jul-2025 to pay taxes on vested RSUs.

How many ANIP shares does Meredith Cook now own?

After the transaction, she directly holds 76,874 common shares.

Was this an open-market sale of ANIP stock?

No. The Code F designation indicates shares were withheld by the company for tax purposes, not sold on the market.

Does the Form 4 affect ANIP’s earnings or guidance?

No operational or financial guidance was provided; the filing only details insider share movements.

Is the 2,071-share disposition material to ANIP shareholders?

At ≈ $137k and <0.01% of shares outstanding, the impact is not material to valuation or float.
Sps Commerce

NASDAQ:SPSC

SPSC Rankings

SPSC Latest News

SPSC Latest SEC Filings

SPSC Stock Data

5.35B
37.62M
0.87%
102.52%
3.4%
Software - Application
Services-prepackaged Software
Link
United States
MINNEAPOLIS